Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for AYTU BIOPHARMA, INC in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
B
BlackRock, Inc.
|
9.2M | 47.81% | +889.1K (+10.6%) | 2023 | 0.0% | |
|
Shares held by quarter
Peak holding9.2M (Q2'26)
Change over 8 quarters+6.5M
Share of the company47.810%
|
||||||
|
EC
Encompass Capital Advisors LLC
|
6.6M | 33.95% | −350.3K (−5.1%) | Q1 '26 | 1.5% | |
|
Shares held by quarter
Peak holding6.9M (Q1'26)
Change over 8 quarters+6.6M
Share of the company33.950%
|
||||||
28 more super investors behind a free account
See every manager holding AYTU BIOPHARMA, INC, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$22.7M | 3.8M | 19.47% | 0.00% | June 30, 2026 |
|
IR
iShares Trust
|
$18.9M | 3.0M | 15.74% | 0.02% | June 30, 2026 |
23 more funds behind a free account
See every fund holding AYTU BIOPHARMA, INC and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
BC
Brooke Christopher
Insider
|
1.2M | 6.04% | — | — |
— | — |
|
Insider holdings come from Form 3/4/5 filings, which are not quarterly.
Share of the company6.040%
|
||||||
|
MD
Mack Daniel
5%+ holder
13D · 14.4%
|
1.1M | 5.62% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
9 more holders behind a free account
See every insider and 5%+ holder of AYTU BIOPHARMA, INC.
Sign up freeLoading...